Literature DB >> 18156490

U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency.

Mirko Pinotti1, Lara Rizzotto, Dario Balestra, Marzena Anna Lewandowska, Nicola Cavallari, Giovanna Marchetti, Francesco Bernardi, Franco Pagani.   

Abstract

Small nuclear U1-RNAs (snRNAs), the spliceosome components selectively recognizing donor splice sites (5'ss), were engineered to restore correct mRNA processing in a cellular model of severe coagulation factor VII (FVII) deficiency, caused by the IVS7 9726 + 5g/a change. Three U1-snRNAs, complementary to the mutated 5'ss (U1 + 5a) or to neighboring sequences were expressed with FVII minigenes in a hepatoma cell line. The U1-snRNAs reduced from 80% to 40% the exon 7 skipping, thus increasing exon definition. The U1 + 5a construct also dramatically increased recognition of the correct 5'ss over the 37-bp downstream cryptic site preferentially activated by the mutation, thus inducing appreciable synthesis of normal transcripts (from barely detectable to 50%). This effect, which was dose-dependent, clearly demonstrated that impaired recognition by the U1-snRNA was the mechanism responsible for FVII deficiency. These findings suggest compensatory U1-snRNAs as therapeutic tools in coagulation factor deficiencies caused by mutations at 5'ss, a frequent cause of severe defects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18156490     DOI: 10.1182/blood-2007-10-117440

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

Review 1.  mRNA transcript diversity creates new opportunities for pharmacological intervention.

Authors:  Elizabeth S Barrie; Ryan M Smith; Jonathan C Sanford; Wolfgang Sadee
Journal:  Mol Pharmacol       Date:  2012-02-07       Impact factor: 4.436

2.  Localizing the RPGR protein along the cilium: a new method to determine efficacies to treat RPGR mutations.

Authors:  R Da Costa; E Glaus; A Tiwari; B Kloeckener-Gruissem; W Berger; J Neidhardt
Journal:  Gene Ther       Date:  2015-01-29       Impact factor: 5.250

Review 3.  Therapeutic approaches to treat human spliceosomal diseases.

Authors:  Anthony B DeNicola; Yi Tang
Journal:  Curr Opin Biotechnol       Date:  2019-02-15       Impact factor: 9.740

4.  Correct mRNA processing at a mutant TT splice donor in FANCC ameliorates the clinical phenotype in patients and is enhanced by delivery of suppressor U1 snRNAs.

Authors:  Linda Hartmann; Kornelia Neveling; Stephanie Borkens; Hildegard Schneider; Marcel Freund; Elke Grassman; Stephan Theiss; Angela Wawer; Stefan Burdach; Arleen D Auerbach; Detlev Schindler; Helmut Hanenberg; Heiner Schaal
Journal:  Am J Hum Genet       Date:  2010-10-08       Impact factor: 11.025

5.  Upregulation of functional Kv11.1a isoform expression by modified U1 small nuclear RNA.

Authors:  Qiuming Gong; Matthew R Stump; Zhengfeng Zhou
Journal:  Gene       Date:  2017-10-21       Impact factor: 3.688

6.  U1 snRNA mis-binding: a new cause of CMT1B.

Authors:  Hervé Crehalet; Philippe Latour; Véronique Bonnet; Shahram Attarian; Pierre Labauge; Nathalie Bonello; Rafaelle Bernard; Gilles Millat; Robert Rousson; Dominique Bozon
Journal:  Neurogenetics       Date:  2009-05-28       Impact factor: 2.660

Review 7.  Targeting RNA splicing for disease therapy.

Authors:  Mallory A Havens; Dominik M Duelli; Michelle L Hastings
Journal:  Wiley Interdiscip Rev RNA       Date:  2013-03-19       Impact factor: 9.957

8.  An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects.

Authors:  Eugenio Fernandez Alanis; Mirko Pinotti; Andrea Dal Mas; Dario Balestra; Nicola Cavallari; Malgorzata E Rogalska; Francesco Bernardi; Franco Pagani
Journal:  Hum Mol Genet       Date:  2012-02-23       Impact factor: 6.150

9.  Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides.

Authors:  Dario Balestra; Elena Barbon; Daniela Scalet; Nicola Cavallari; Daniela Perrone; Silvia Zanibellato; Francesco Bernardi; Mirko Pinotti
Journal:  Hum Mol Genet       Date:  2015-06-10       Impact factor: 6.150

10.  Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant.

Authors:  Nicola Cavallari; Dario Balestra; Alessio Branchini; Iva Maestri; Ampaiwan Chuamsunrit; Werasak Sasanakul; Guglielmo Mariani; Franco Pagani; Francesco Bernardi; Mirko Pinotti
Journal:  Biochim Biophys Acta       Date:  2012-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.